Biofilms in chronic infections

Biofilm Formation - It Takes a Village

• Stage 1: Attachment
  • Reversible adhesion of free-swimming (planktonic) bacteria to a surface (e.g., catheters, implants).
• Stage 2: Adhesion & Colonization
  • Irreversible binding, followed by proliferation into protective microcolonies.
• Stage 3: EPS Production
  • Secretion of an Extracellular Polymeric Substance (EPS) matrix-a protective slime of polysaccharides, proteins, and eDNA that confers antibiotic resistance.
• Stage 4: Maturation & Dispersal
  • The biofilm matures; some bacteria detach to colonize new sites.

⭐ Quorum sensing orchestrates this entire process. Bacteria release signaling molecules (autoinducers); once a critical concentration is reached, it triggers coordinated gene expression for EPS production and virulence.

Pathogenesis & Resistance - The Fortress of Infection

• Physical Barrier (EPS Matrix):
  • The slimy extracellular polymeric substance (EPS) matrix acts as a physical shield.
  • Blocks host immune cells (↓ phagocytosis), antibodies, and complement activation.
• Mechanisms of Extreme Resistance:
  • Limited Drug Penetration: The dense EPS matrix physically obstructs antibiotic diffusion.
  • Slow Growth State: Bacteria in the biofilm's deeper layers have low metabolic activity, making them tolerant to antibiotics that target growth (e.g., β-lactams).
  • Persister Cells: A subpopulation of dormant cells that are highly resistant to antibiotics; they can repopulate the biofilm after therapy ceases.
  • Horizontal Gene Transfer: Close cell proximity facilitates the efficient exchange of resistance plasmids.

⭐ Biofilm-based infections may require antibiotic concentrations 100-1000 times higher than the standard Minimum Inhibitory Concentration (MIC) to be effective.

Clinical Examples - The Usual Suspects

• Pseudomonas aeruginosa: Classic cause of chronic pneumonia in Cystic Fibrosis. Its mucoid alginate exopolysaccharide creates a protective biofilm in the airways.
• Staphylococcus epidermidis: The most common cause of infections on indwelling medical devices like catheters, prosthetic heart valves, and artificial joints.
• Staphylococcus aureus: A key agent in chronic osteomyelitis, endocarditis, and persistent wound infections. Biofilm protects it from host defenses and antibiotics.
• Viridans Group Streptococci (S. mutans): Primary colonizers of dental surfaces, forming plaque that leads to dental caries and gingivitis. Can seed and cause subacute native valve endocarditis.
• Non-typeable Haemophilus influenzae: A frequent cause of recurrent otitis media in children, forming biofilms in the middle ear.

⭐ The quorum-sensing system in P. aeruginosa coordinates the expression of virulence factors and biofilm formation, making it a prime target for novel anti-biofilm therapies.

High‑Yield Points - ⚡ Biggest Takeaways

• Biofilms are microbial communities encased in a self-produced extracellular polymeric substance (EPS), shielding them from threats.
• This matrix confers high resistance to antibiotics and host immune responses, causing chronic, persistent infections.
• Key examples: P. aeruginosa in cystic fibrosis lungs, S. epidermidis on catheters, and dental plaque.
• Quorum sensing is the cell-to-cell communication system that regulates biofilm formation.
• Treatment often requires physical removal of the biofilm source (e.g., infected device).